Nebulized Fentanyl for Respiratory Symptoms in Patients With COVID-19

Clinical trial NCT05165992 · UNKNOWN

Trial details

NCT number: NCT05165992
Sponsor: Hamad Medical Corporation
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

COVID-19 Pneumonia

Start date: 2022-02-01
Primary completion: 2022-11-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.